This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Gelteq centers its technology on a proprietary, customizable gel platform designed for precise drugdelivery, supporting prescription drugs, nutraceuticals, pet care and sports supplements. Priced at $4.0
From the Human Genome Project to contemporary drug development, collaboration is critical to the lifesciences. It is also an important factor in the success of lifesciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.
Highlights include expansion of biotech operations in Philadelphia, acquisition of a new pharma-device facility near Dublin, Ireland, and a new Center of Excellence for advanced drugdelivery and drug-device combination product assembly in Rockford, Illinois.
Its lead candidate, PL-14, targets nasal allergies and is scheduled for US Food and Drug Administration (FDA) submission via the 510(k) pathway, with preclinical trials expected to start in the second quarter of 2025 and pivotal trials by the end of 2025.
Ireland-based Fountain Healthcare Partners has raised another €125 million ($131 million) for its third lifesciences fund – 25% ahead of its target – and says it will pump most of the money into European therapeutics and medical device companies. The third fund is now closed.
TriSalus LifeSciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of SD-101 via Pressure-Enabled DrugDelivery in Uveal Melanoma Liver Metastases TriSalus LifeSciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of … Continue reading →
As Chief Medical and Scientific Officer at Click Therapeutics and a Board Director at SpineThera, he spearheads AI-enabled clinical development and drug-delivery platforms. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
The team also learned about the FDA approval of Genentech’s new ocular implant drugdelivery system, called Susvimo, for the treatment of neovascular, or wet, age-related macular degeneration (nAMD). Genentech’s New Ocular Implant DrugDelivery System for Macular Degeneration Could Be a Game Changer.
Samyang Holdings Biopharm Division CEO Young-Joon Lee stated: “LG Chem has exceptional research and development expertise in innovative drug development and a number of promising new drug pipelines. This is expected to shorten the development time of new drugs and to support personalised treatments.
SHL Medical is a world-leading solutions provider for advanced drugdelivery systems with a unified purpose to further enable patient independence. Consequently, pharmaceutical and biotech companies are increasingly looking to provide devices that allow patients to self-administer drugs.
Employee retention and motivation is a challenge that all lifescience companies face. Lifescience companies often have to follow a complex regulatory framework that is associated with high risks, which is why maintaining corporate compliance is essential. Training and Development Opportunities.
Ayesha also talked about the FDA approval of AstraZeneca’s asthma inhaler Airsupra, the first-in-class drug that contains both a beta agonist and corticosteroid. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode. Hear more about the new subvariant and why scientists are keeping a close eye on it.
LillyDirect Pharmacy Solutions, Eli Lilly’s direct-to-consumer (DTC) drugs website, is teaming up with Amazon Pharmacy to deliver select medications to people’s homes. The drugs include Lilly’s newly approved GLP-1 obesity drug Zepbound (tirzepatide), around a dozen of the company’s insulins and migraine drug Emgality (galcanezumab).
These issues primarily stem from patients and healthcare providers miscalculating or incorrectly administering the drug. Compounded semaglutide products, unlike the US Food and Drug Administration (FDA)-approved ones, can vary widely in strength and packaging, making it easy for mistakes to happen.
For the Sarclisa ® subcutaneous formulation delivery, Sanofi has partnered with drugdelivery technology innovator company Enable Injections , Inc. to advance the development of a subcutaneous delivery for Sarclisa ® with the goal of offering a unique patient-centric treatment experience. About Blackstone LifeSciences.
A representative from the small-molecule solutions company explains how the ever-increasing mountain of life-sciences data has impacted drug development.
Hayley Crowe is executive vice president and general manager of Ecolabâs Global LifeSciences sector, comprised of Ecolabâs Purolite and pharma / personal care businesses.
The US Food and Drug Administration (FDA) has approved Galderma’s monoclonal antibody Nemluvio (nemolizumab) for the treatment of adult patients with the chronic skin condition prurigo nodularis. Monoclonal antibody therapy has been found to have fewer side effects when compared to immunosuppressant drugs.
This extension will further help connect life-science innovators in Victoria to accelerate their healthcare solutions across the globe,” said Stacy Feld, Regional Head, Johnson & Johnson Innovation LLC, West North America, Australia & New Zealand.
“By offering all-in-one solutions, including drugdelivery connected devices, digital therapeutics, and care services, we aim to reduce existing gaps in healthcare by empowering patients, improving treatment adherence, and strengthening the patient and care team relationship,” said Touya.
According to an analysis of the 2013 Medical Expenditure Panel Survey, one in six US adults reported taking a psychiatric drug at least once in 2013. CNS drugs treat a range of neurologic and psychiatric disorders, such as psychosis, depression, Parkinson’s disease, multiple sclerosis and epilepsy.
percent received approval from the US Food and Drug Administration (FDA) to treat dry eye disease. Attendees will understand best practices for novel drugdelivery design and development. Attendees will understand best practices for novel drugdelivery design and development. What Is Dry Eye Disease?
In this interview, Xtalks spoke with two industry experts from Alira Health , Giulia Pierini , Principal of Patient Engagement, and Eduardo Perez-Guagnelli , PhD, Patient-Centric Co-Design Lead, about how lifesciences companies can adopt patient-centric co-design in their product development.
The rankings are based on each companys ability to tackle critical challenges from drugdelivery and diagnostics to personalized therapies using cutting-edge science. Recursion Recursion launched the LOWE AI-driven drug discovery platform, reporting $51.1 Here are 20 companies leading the way in 2025.
Sanofi has agreed a deal with lifesciences investor Blackstone to help fund clinical trials of a new formulation of Sarclisa for blood cancer multiple myeloma, accelerating its development. Sanofi has partnered with drugdelivery specialist Enable Injections to develop the subcutaneous formulation.
XTALKS WEBINAR: Enhancing Distributed Manufacturing and Vaccine Distribution through Blow-Fill-Seal Prefilled DrugDelivery Platforms Live and On-Demand: Thursday, February 27, 2025, at 1pm EST (10am PST) Register for this free webinar to learn critical considerations for improving global vaccine and healthcare delivery and outcomes.
However, several drugdelivery devices that enable patients to self-administer their respective medications are now available. Biologics have emerged as a direct consequence of the rapid development that has taken place in the field of lifesciences, particularly in cell and molecular biology, over the past few decades.
Kirkpatrick about Ensysce Biosciences’ innovation in the battle against prescription drug abuse and overdose. Lynn Kirkpatrick, PhD CEO, Ensysce Biosciences Ensysce Biosciences has a pioneering two-step trypsin activation technology, designed to revolutionize drugdelivery across a broad spectrum of medications.
The two venerable Indiana institutions – Lilly headquartered in Indianapolis and Purdue in nearby West Lafayette – have been working together for many years, collaborating on lifesciences research in areas such as new delivery systems for injectable medicines and predictive models for clinical research.
This Hanson Wade event is aimed at experts looking to deliver CNS drug candidates safely and successfully across the blood-brain barrier (BBB). Uncover advances in CNS gene therapy , new generation vectors for intravenous delivery, and the challenges of scaling up for CNS delivery beyond highly specialized centers.
Construction of commercial drug manufacturing facility in Germany.
Psychedelic transdermal and sublingual drug formulation development.
Vektor will position itself for commercial manufacturing, pipeline development and drug formulations for critical mental health conditions.
Excipients can take many forms, such as bulking agents, binders, coatings and colourants, and they are chosen based on their ability to aid in drugdelivery, administration and even in pill identification and prevention of counterfeiting.
The US Food and Drug Administration (FDA) recently approved Boston Scientific’s Agent drug-coated balloon (DCB) for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease (CAD). Key Features of the Agent Drug-Coated Balloon One of the standout features of the Agent DCB is its TransPax Coating Technology.
Approved by the US Food and Drug Administration (FDA) in May 2023, Arexvy is designed to prevent lower respiratory tract disease (LRTD) caused by RSV in older adults. Each “RSV season” spans the months when RSV infections typically rise and fall. No new safety issues emerged over the course of the three seasons.
For healthcare and lifesciences industries, Skin Cancer Awareness Month helps highlight the importance of preventive measures and early detection. Drugs such as pembrolizumab (Merck’s Keytruda) and nivolumab (Bristol Myers Squibb’s Opdivo) have revolutionized the treatment options for skin cancer.
As Amazon continues to ramp up its healthcare portfolio, the online behemoth rolled out RxPass last week, a flat fee drug program through which customers can buy an unlimited amount of commonly prescribed generic medications for $5 a month. The list of available medicines includes about 50 generic drugs.
Highly experienced lifesciences executive that brings large pharma and biotech experience. John will be joining the Board as the representative for Oxford Sciences Innovation (OSI), one of the Company’s major shareholders. About Oxford Sciences Innovation. OXFORD, England , Jan.
The US Food and Drug Administration (FDA) granted approval to AstraZeneca’s Airsupra (albuterol/budesonide), formerly known as PT027, for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma attacks in individuals aged 18 years and older who have asthma.
Now, instead of reaching for reading glasses, AbbVie’s eyedrop formulation Vuity could offer help in correcting far-sightedness as the US Food and Drug Administration (FDA) granted approval to it late last week. Related: Genentech’s New Ocular Implant DrugDelivery System for Macular Degeneration Could Be a Game Changer.
The lifesciences unit of Google parent Alphabet – which raised $1 billion back in September to fund its precision health agenda and business development activities, including possible acquisitions – said the move would allow it to streamline its operations.
According to the company, it is an attempt to focus on its core businesses which include retail pharmacy, health insurance, prescription drug coverage and health care and wellness. The company will gradually wind down its CVS Health Clinical Trial Services unit with full exit by December 31, 2024.
In a new regulatory milestone, the US Food and Drug Administration (FDA) has approved Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq), introducing the first-ever subcutaneous injection option for relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). billion in 2024 to $38.94
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content